K301

· Moberg Pharma AB

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for K301, covering 2010-06-04 to 2010-06-04. Get the full timeline:

Most recent: Clinical Trial Update: K301 for the Treatment of Seborrhoeic Eczema (SE) of the Scalp [Phase 3]